Switchpoint Bio
Developing a blood-based epigenomics platform for disease biology and treatment response in drug development.
Website: https://www.switchpointbio.com/
Articles about Switchpoint Bio
- Switchpoint Bio's Blood-Based Epigenomics Platform Aims to Decode Drug Response — The pre-seed startup, founded by veterans of Blueprint Genetics and Harvard epigenomics, is using routine blood draws to give drug developers a dynamic read on biology.